1. Home
  2. ELUT vs NCSM Comparison

ELUT vs NCSM Comparison

Compare ELUT & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • NCSM
  • Stock Information
  • Founded
  • ELUT 2015
  • NCSM 2006
  • Country
  • ELUT United States
  • NCSM United States
  • Employees
  • ELUT N/A
  • NCSM N/A
  • Industry
  • ELUT Medical Specialities
  • NCSM Oilfield Services/Equipment
  • Sector
  • ELUT Health Care
  • NCSM Energy
  • Exchange
  • ELUT Nasdaq
  • NCSM Nasdaq
  • Market Cap
  • ELUT 94.0M
  • NCSM 81.3M
  • IPO Year
  • ELUT 2020
  • NCSM 2017
  • Fundamental
  • Price
  • ELUT $1.76
  • NCSM $28.65
  • Analyst Decision
  • ELUT Strong Buy
  • NCSM
  • Analyst Count
  • ELUT 2
  • NCSM 0
  • Target Price
  • ELUT $8.00
  • NCSM N/A
  • AVG Volume (30 Days)
  • ELUT 32.9K
  • NCSM 8.0K
  • Earning Date
  • ELUT 05-08-2025
  • NCSM 04-30-2025
  • Dividend Yield
  • ELUT N/A
  • NCSM N/A
  • EPS Growth
  • ELUT N/A
  • NCSM N/A
  • EPS
  • ELUT N/A
  • NCSM 3.27
  • Revenue
  • ELUT $23,711,000.00
  • NCSM $168,704,000.00
  • Revenue This Year
  • ELUT $37.67
  • NCSM $7.22
  • Revenue Next Year
  • ELUT $63.22
  • NCSM $5.43
  • P/E Ratio
  • ELUT N/A
  • NCSM $8.85
  • Revenue Growth
  • ELUT N/A
  • NCSM 18.16
  • 52 Week Low
  • ELUT $1.61
  • NCSM $15.90
  • 52 Week High
  • ELUT $5.24
  • NCSM $38.95
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 42.03
  • NCSM 40.74
  • Support Level
  • ELUT $1.61
  • NCSM $31.12
  • Resistance Level
  • ELUT $1.85
  • NCSM $31.43
  • Average True Range (ATR)
  • ELUT 0.13
  • NCSM 1.32
  • MACD
  • ELUT 0.02
  • NCSM -0.39
  • Stochastic Oscillator
  • ELUT 50.00
  • NCSM 0.17

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

Share on Social Networks: